Main
            
                            
                Perm. 1
                Haven 
            
                    
                Perm. 2
                Ascent 
            
            kda
                        +/-
                        ACS
                        Pering. 3.0
                        KAST
                        ADR
                        hs%
                        Dampak
                        fk
                        fd
                        F+/-
                        mk
                        Perdag.
                        Kopl.
                    
                                    36 / 22 / 8
                                                                    
                                
                                    +14
                                                                    
                                
                                    271.32
                                                                    
                                
                                    1.44
                                                                    
                                
                                    70.05%
                                                                    
                                
                                    168.00
                                                                    
                                
                                    23%
                                                                    
                                
                                    370
                                                                    
                                
                                    10
                                                                    
                                
                                    4
                                                                    
                                
                                    +6
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    36 / 21 / 8
                                                                    
                                
                                    +15
                                                                    
                                
                                    255.30
                                                                    
                                
                                    1.42
                                                                    
                                
                                    81.03%
                                                                    
                                
                                    173.46
                                                                    
                                
                                    34%
                                                                    
                                
                                    184
                                                                    
                                
                                    6
                                                                    
                                
                                    1
                                                                    
                                
                                    +5
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    29 / 21 / 7
                                                                    
                                
                                    +8
                                                                    
                                
                                    209.51
                                                                    
                                
                                    1.15
                                                                    
                                
                                    70.30%
                                                                    
                                
                                    145.65
                                                                    
                                
                                    17%
                                                                    
                                
                                    194
                                                                    
                                
                                    5
                                                                    
                                
                                    3
                                                                    
                                
                                    +2
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    33 / 25 / 14
                                                                    
                                
                                    +8
                                                                    
                                
                                    254.35
                                                                    
                                
                                    1.13
                                                                    
                                
                                    84.14%
                                                                    
                                
                                    159.22
                                                                    
                                
                                    18%
                                                                    
                                
                                    0
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    0
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    21 / 26 / 18
                                                                    
                                
                                    -5
                                                                    
                                
                                    154.78
                                                                    
                                
                                    0.74
                                                                    
                                
                                    75.59%
                                                                    
                                
                                    92.51
                                                                    
                                
                                    15%
                                                                    
                                
                                    76
                                                                    
                                
                                    2
                                                                    
                                
                                    6
                                                                    
                                
                                    -4
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            kda
                        +/-
                        ACS
                        Pering. 3.0
                        KAST
                        ADR
                        hs%
                        Dampak
                        fk
                        fd
                        F+/-
                        mk
                        Perdag.
                        Kopl.
                    
                                    31 / 33 / 5
                                                                    
                                
                                    -2
                                                                    
                                
                                    242.97
                                                                    
                                
                                    1.19
                                                                    
                                
                                    65.08%
                                                                    
                                
                                    156.62
                                                                    
                                
                                    26%
                                                                    
                                
                                    363
                                                                    
                                
                                    10
                                                                    
                                
                                    10
                                                                    
                                
                                    0
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    31 / 31 / 13
                                                                    
                                
                                    0
                                                                    
                                
                                    249.14
                                                                    
                                
                                    1.11
                                                                    
                                
                                    73.41%
                                                                    
                                
                                    165.11
                                                                    
                                
                                    21%
                                                                    
                                
                                    88
                                                                    
                                
                                    2
                                                                    
                                
                                    3
                                                                    
                                
                                    -1
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    19 / 30 / 12
                                                                    
                                
                                    -11
                                                                    
                                
                                    150.59
                                                                    
                                
                                    0.73
                                                                    
                                
                                    70.22%
                                                                    
                                
                                    101.59
                                                                    
                                
                                    25%
                                                                    
                                
                                    30
                                                                    
                                
                                    1
                                                                    
                                
                                    3
                                                                    
                                
                                    -2
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    16 / 28 / 7
                                                                    
                                
                                    -12
                                                                    
                                
                                    129.57
                                                                    
                                
                                    0.63
                                                                    
                                
                                    56.68%
                                                                    
                                
                                    89.16
                                                                    
                                
                                    17%
                                                                    
                                
                                    3
                                                                    
                                
                                    -
                                                                    
                                
                                    2
                                                                    
                                
                                    -2
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    17 / 34 / 8
                                                                    
                                
                                    -17
                                                                    
                                
                                    139.03
                                                                    
                                
                                    0.60
                                                                    
                                
                                    57.00%
                                                                    
                                
                                    83.68
                                                                    
                                
                                    21%
                                                                    
                                
                                    50
                                                                    
                                
                                    1
                                                                    
                                
                                    5
                                                                    
                                
                                    -4
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            Bandar taruhan
                    
                        Bleed
                        vs
                        FATAL
                    
                Pertandingan sebelumnya
Tanggal
                Pertandingan
                Acara
            
                                    
                    
                        
                            2022-03-27 03:30:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        1
                                    
                                    -
                                    
                                        2
                                    
                                                            
                            
                                XERXIA
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: APAC Stage 1 Challengers
                        
                        
                    
                                    
                    
                        
                            2022-03-26 07:55:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        0
                                    
                                    -
                                    
                                        2
                                    
                                                            
                            
                                Paper Rex
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: APAC Stage 1 Challengers
                        
                        
                    
                                                                                
                    
                        
                            2022-03-25 03:30:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        1
                                    
                                                            
                            
                                FULL SENSE
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: APAC Stage 1 Challengers
                        
                        
                    
                                    
                    
                        
                            2022-03-24 06:00:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        1
                                    
                                                            
                            
                                MI Thailand
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: APAC Stage 1 Challengers
                        
                        
                    
                                                                                
                    
                        
                            2022-03-16 10:10:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        1
                                    
                                                            
                            
                                NAOS Esp
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: APAC Stage 1 Challengers
                        
                        
                    
                                                                                
                    
                        
                            2022-02-27 06:00:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        0
                                    
                                    -
                                    
                                        3
                                    
                                                            
                            
                                Paper Rex
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: Malaysia & Singapore Stage 1 Challengers
                        
                        
                    
                                                                                
                    
                        
                            2022-02-27 03:30:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        0
                                    
                                                            
                            
                                No Namers
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: Malaysia & Singapore Stage 1 Challengers
                        
                        
                    
                                                                                
                    
                        
                            2022-02-26 11:00:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        1
                                    
                                                            
                            
                                HZ
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: Malaysia & Singapore Stage 1 Challengers
                        
                        
                    
                            
        Pertandingan sebelumnya
Tanggal
                Pertandingan
                Acara
            Informasi acara
                    VALORANT Champions Tour 2022: Malaysia & Singapore Stage 1 Challengers
                    
                                                    2022-02-10 00:00:00
                            -
                            2022-02-27 00:00:00
                                            
                
            
                    34
                    Pert.
                
                                    
                        $23,828
                        Pusat hadiah
                    
                                
                    B-Tier
                    Tingkat
                
            
                                    Group A
                                
                                                            
                                    Group B
                                
                                                            
                                    Group C
                                
                                                            
                                    Group D
                                
                                                    Group A
            Pert.
            Rounds
            RD